Coleen K. Cunningham
- Virology top 0.5%
- HIV Research and Treatment 49
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions 53
- HIV/AIDS drug development and treatment 23
- Epidemiology top 2%
- Respiratory viral infections research 28
- Pneumonia and Respiratory Infections 18
- Pneumocystis jirovecii pneumonia detection and treatment 11
- Hepatitis B Virus Studies 11
- Influenza Virus Research Studies 9
- Emergency Medicine top 2%
- Immunology top 5%
- Co-authors
- Dorothy E. DowJulia A. McMillanBlandina T. MmbagaSteven Jay GrossAisa ShayoLeonard B. WeinerElizabeth L. TurnerCynthia A. Bonville
- Journals
- The Pediatric Infectious Disease Journal (15 papers)The Journal of Infectious Diseases (11 papers)PLoS ONE (8 papers)
- Partner nations
- United StatesTanzaniaBotswana
In The Last Decade
Coleen K. Cunningham
130 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 133
- Virology 1.0k
- Infectious Diseases 2.0k
- Epidemiology 1.6k
- Emergency Medicine 331
- Immunology 511
Countries citing papers authored by Coleen K. Cunningham
This map shows the geographic impact of Coleen K. Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coleen K. Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coleen K. Cunningham more than expected).
Fields of papers citing papers by Coleen K. Cunningham
This network shows the impact of papers produced by Coleen K. Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coleen K. Cunningham. The network helps show where Coleen K. Cunningham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Coleen K. Cunningham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for all infants born in high-burden settings | 2022 | 1 |
| 3 | 2021 | 6 | |
| 4 | 2020 | 42 | |
| 5 | 2019 | 9 | |
| 6 | 2018 | 23 | |
| 7 | 2017 | 25 | |
| 8 | 2016 | 128 | |
| 9 | Safety and immunogenicity of the recombinant live-attenuated respiratory syncytial virus vaccine RSV cps2 in RSV-seronegative infants and children | 2015 | 1 |
| 10 | 2015 | 17 | |
| 11 | 2013 | 5 | |
| 12 | 2010 | 74 | |
| 13 | 2009 | 5 | |
| 14 | 2009 | 10 | |
| 15 | 2008 | 6 | |
| 16 | 2004 | 79 | |
| 17 | 2004 | 28 | |
| 18 | 2004 | 7 | |
| 19 | 2002 | 32 | |
| 20 | 1991 | 196 |
About Coleen K. Cunningham
Coleen K. Cunningham is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 133 papers that have together received 3.7k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (53 papers), HIV Research and Treatment (49 papers), Respiratory viral infections research (28 papers), HIV/AIDS drug development and treatment (23 papers), Pneumonia and Respiratory Infections (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), Hepatitis B Virus Studies (11 papers) and Influenza Virus Research Studies (9 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (2.0k citations) and Epidemiology (1.6k citations). Coleen K. Cunningham has collaborated with scholars based in United States, Tanzania and Botswana. Frequent co-authors include Dorothy E. Dow, Julia A. McMillan, Blandina T. Mmbaga, Steven Jay Gross, Aisa Shayo, Leonard B. Weiner, Elizabeth L. Turner, Cynthia A. Bonville, Lynne Mofenson and Robert F. Betts. Their work appears in journals such as The Pediatric Infectious Disease Journal, The Journal of Infectious Diseases, PLoS ONE, Journal of the Pediatric Infectious Diseases Society and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.